We have located links that may give you full text access.
Costo Efectividad De La Adici"N De Bevacizumab Al Esquema De Primera Línea De Quimioterapia Carboplatino + Paclitaxel En Pacientes Con Cáncer De Pulm"N De Celula No Pequeña No Escamosa Con Ecog Entre 0 Y 1.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research 2015 November
No abstract text is available yet for this article.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app